Cargando…

Current update on the visual outcome of optic pathway glioma associated with neurofibromatosis type-1

PURPOSE: Clinical and diagnostic evaluation in the follow-up of optic glioma patients with neurofibromatosis type 1 (NF-1) can be difficult. Determining whether and when to provide treatment is a significant challenge in best managing these patients. Update on current information and future directio...

Descripción completa

Detalles Bibliográficos
Autor principal:	Zeid, Janice Lasky
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Surgery
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9478197/ https://www.ncbi.nlm.nih.gov/pubmed/36117804 http://dx.doi.org/10.3389/fsurg.2022.908573

Ejemplares similares

Optic Pathway Glioma in Children with Neurofibromatosis Type 1: A Multidisciplinary Entity, Posing Dilemmas in Diagnosis and Management Multidisciplinary Management of Optic Pathway Glioma in Children with Neurofibromatosis Type 1
por: Lohkamp, Laura-Nanna, et al.
Publicado: (2022)

Neurofibromatosis Type 1-Associated Optic Pathway Gliomas: Current Challenges and Future Prospects
por: Tang, Yunshuo, et al.
Publicado: (2023)

An Update on Neurofibromatosis Type 1-Associated Gliomas
por: Lobbous, Mina, et al.
Publicado: (2020)

Morning glory disc anomaly and ipsilateral sporadic optic pathway glioma
por: Kinori, Michael, et al.
Publicado: (2018)

Progressive ectropion uveae and secondary angle-closure glaucoma in type 1 neurofibromatosis
por: Esfandiari, Hamed, et al.
Publicado: (2022)

MRI Screening for Optic Gliomas in Neurofibromatosis Type 1
por: Millichap, J. Gordon
Publicado: (2015)

Neurosurgery for Optic Pathway Glioma: Optimizing Multidisciplinary Management
por: Samples, Derek C., et al.
Publicado: (2022)

Optic pathway glioma and the sex association in neurofibromatosis type 1: a single-center study
por: Henning, Anne Munk, et al.
Publicado: (2021)

Rethinking the Management of Optic Pathway Gliomas: A Single Center Experience
por: Del Baldo, Giada, et al.
Publicado: (2022)

Optic pathway glioma, scoliosis, Chiari type 1 malformation, and syringomyelia in a patient with neurofibromatosis type 1
por: Incecık, Faruk, et al.
Publicado: (2013)

Editorial: Optic pathway glioma: A multidisciplinary entity, posing dilemmas in diagnosis and management
por: Habibi, Zohreh, et al.
Publicado: (2022)

Optic Pathway Glioma in Type 1 Neurofibromatosis: Review of Its Pathogenesis, Diagnostic Assessment, and Treatment Recommendations
por: Cassina, Matteo, et al.
Publicado: (2019)

RONC-05. PRESERVING VISION IN OPTIC PATHWAY GLIOMA AMONG PATIENTS WITHOUT NEUROFIBROMATOSIS TYPE 1
por: Hanania, Alexander, et al.
Publicado: (2020)

Optic Pathway–Hypothalamic Glioma Apoplexy: A Report of Two Cases and Systematic Review of the Literature
por: Baeesa, Saleh, et al.
Publicado: (2022)

Non-optic glioma in adults and children with neurofibromatosis 1
por: Sellmer, Laura, et al.
Publicado: (2017)

Rare Case of Optic Pathway Glioma with Extensive Intra-Ocular Involvement in a Child with Neurofibromatosis Type 1
por: Gupta, Vasudha, et al.
Publicado: (2015)

Laparoscopic retroperitoneal resection of the duodenal gastrointestinal stromal tumors in neurofibromatosis type 1; Case Report and literature review
por: Abdullah, Al-Danakh, et al.
Publicado: (2022)

Primary Bone Leiomyosarcoma in Neurofibromatosis Type 1: Extremely Rare Concurrency
por: Abualjubain, Izzeddin J, et al.
Publicado: (2021)

Intra-Orbital Meningioma Causing Loss of Vision in Neurofibromatosis Type 2: Case Series and Management Considerations
por: Lekovic, Gregory P., et al.
Publicado: (2018)

Monomodality versus Combined Therapy in Optic Pathway Gliomas—20-Year Experience from a Singapore Children’s Hospital
por: Lim, Jia Xu, et al.
Publicado: (2022)

Quantitative Modulation of PpIX Fluorescence and Improved Glioma Visualization
por: Reinert, Michael, et al.
Publicado: (2019)

Risk of Optic Pathway Glioma in Neurofibromatosis Type 1: No Evidence of Genotype–Phenotype Correlations in a Large Independent Cohort
por: Melloni, Giulia, et al.
Publicado: (2019)

A case of neurofibromatosis 1 presenting with optic pathway glioma with an early onset and an aggressive course
por: Ganesh, Suma, et al.
Publicado: (2008)

Corrigendum: Quantitative Modulation of PpIX Fluorescence and Improved Glioma Visualization
por: Reinert, Michael, et al.
Publicado: (2020)

Non-Coding RNA and Tumor Development in Neurofibromatosis Type 1: ANRIL Rs2151280 Is Associated with Optic Glioma Development and a Mild Phenotype in Neurofibromatosis Type 1 Patients
por: Tritto, Viviana, et al.
Publicado: (2019)

Identification of Mutation Regions on NF1 Responsible for High- and Low-Risk Development of Optic Pathway Glioma in Neurofibromatosis Type I
por: Xu, Min, et al.
Publicado: (2018)

Quantitative MRI demonstrates abnormalities of the third ventricle subventricular zone in neurofibromatosis type-1 and sporadic paediatric optic pathway glioma
por: Boonzaier, Natalie R., et al.
Publicado: (2020)

Serial MRIs provide novel insight into natural history of optic pathway gliomas in patients with neurofibromatosis 1
por: Sellmer, Laura, et al.
Publicado: (2018)

Clinical presentation and prognostic indicators in 100 adults and children with neurofibromatosis 1 associated non-optic pathway brain gliomas
por: Byrne, Susan, et al.
Publicado: (2017)

Visual spatial learning outcomes for clinical trials in neurofibromatosis type 1
por: Ullrich, Nicole J., et al.
Publicado: (2020)

High-Dose Intravenous Vitamin C Treatment of a Child with Neurofibromatosis Type 1 and Optic Pathway Glioma: A Case Report
por: Mikirova, Nina, et al.
Publicado: (2016)

Commentary: Identification of Mutation Regions on NF1 Responsible for High- and Low-Risk Development of Optic Pathway Glioma in Neurofibromatosis Type I
por: Anastasaki, Corina, et al.
Publicado: (2019)

Neurofibromatosis: an update of ophthalmic characteristics and applications of optical coherence tomography
por: Abdolrahimzadeh, Barmak, et al.
Publicado: (2016)

Visual Outcome for Children with Optic Pathway Gliomas Treated with Systemic Chemotherapy
por: Mohammad, Mona, et al.
Publicado: (2022)

Challenges in Drug Discovery for Neurofibromatosis Type 1-Associated Low-Grade Glioma
por: Ricker, Cora A., et al.
Publicado: (2016)

Charcot Neuroarthropathy: Current Surgical Management and Update. A Systematic Review
por: Bajuri, Mohd Yazid, et al.
Publicado: (2022)

An update on the CNS manifestations of neurofibromatosis type 2
por: Coy, Shannon, et al.
Publicado: (2019)

Co‐occurrence of neurofibromatosis type 1 and optic nerve gliomas with autosomal dominant polycystic kidney disease type 2
por: Peces, Ramón, et al.
Publicado: (2020)

Recent Update in Pharmacological Agents for Optic Pathway Glioma
por: Park, Meerim
Publicado: (2022)

Pulsatile enophthalmos, severe esotropia, kinked optic nerve and visual loss in neurofibromatosis type-1
por: Sachdeva, Virender, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_1qctbqq6nbdci019e21ih5j9pt